297 related articles for article (PubMed ID: 12540629)
1. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
Kelly DJ; Zhang Y; Hepper C; Gow RM; Jaworski K; Kemp BE; Wilkinson-Berka JL; Gilbert RE
Diabetes; 2003 Feb; 52(2):512-8. PubMed ID: 12540629
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
3. A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.
Tuttle KR; Anderson PW
Am J Kidney Dis; 2003 Sep; 42(3):456-65. PubMed ID: 12955673
[TBL] [Abstract][Full Text] [Related]
4. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C beta inhibitor LY333531 attenuates intercellular adhesion molecule-1 and monocyte chemotactic protein-1 expression in the kidney in diabetic rats.
Wu Y; Wu G; Qi X; Lin H; Qian H; Shen J; Lin S
J Pharmacol Sci; 2006 Aug; 101(4):335-43. PubMed ID: 16891764
[TBL] [Abstract][Full Text] [Related]
6. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
Koya D; Jirousek MR; Lin YW; Ishii H; Kuboki K; King GL
J Clin Invest; 1997 Jul; 100(1):115-26. PubMed ID: 9202063
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease.
Kelly DJ; Edgley AJ; Zhang Y; Thai K; Tan SM; Cox AJ; Advani A; Connelly KA; Whiteside CI; Gilbert RE
Nephrol Dial Transplant; 2009 Jun; 24(6):1782-90. PubMed ID: 19155535
[TBL] [Abstract][Full Text] [Related]
8. Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy.
Mifsud S; Kelly DJ; Qi W; Zhang Y; Pollock CA; Wilkinson-Berka JL; Gilbert RE
Nephron Physiol; 2003; 95(4):p83-91. PubMed ID: 14694265
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy.
Kelly DJ; Chanty A; Gow RM; Zhang Y; Gilbert RE
J Am Soc Nephrol; 2005 Jun; 16(6):1654-60. PubMed ID: 15843473
[TBL] [Abstract][Full Text] [Related]
10. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice.
Menne J; Park JK; Boehne M; Elger M; Lindschau C; Kirsch T; Meier M; Gueler F; Fiebeler A; Bahlmann FH; Leitges M; Haller H
Diabetes; 2004 Aug; 53(8):2101-9. PubMed ID: 15277392
[TBL] [Abstract][Full Text] [Related]
11. Dual inhibition of classical protein kinase C-α and protein kinase C-β isoforms protects against experimental murine diabetic nephropathy.
Menne J; Shushakova N; Bartels J; Kiyan Y; Laudeley R; Haller H; Park JK; Meier M
Diabetes; 2013 Apr; 62(4):1167-74. PubMed ID: 23434935
[TBL] [Abstract][Full Text] [Related]
12. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
O'Brien RC; Cooper ME; Jerums G; Doyle AE
Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112
[TBL] [Abstract][Full Text] [Related]
13. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.
Nakamura J; Kato K; Hamada Y; Nakayama M; Chaya S; Nakashima E; Naruse K; Kasuya Y; Mizubayashi R; Miwa K; Yasuda Y; Kamiya H; Ienaga K; Sakakibara F; Koh N; Hotta N
Diabetes; 1999 Oct; 48(10):2090-5. PubMed ID: 10512378
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ
Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330
[TBL] [Abstract][Full Text] [Related]
15. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.
Bursell SE; Takagi C; Clermont AC; Takagi H; Mori F; Ishii H; King GL
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2711-20. PubMed ID: 9418723
[TBL] [Abstract][Full Text] [Related]
16. Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes.
Cotter MA; Jack AM; Cameron NE
Clin Sci (Lond); 2002 Sep; 103(3):311-21. PubMed ID: 12193157
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous remission of diabetes arrests progression of nephropathy in streptozotocin-treated spontaneously hypertensive rats.
Iwase M; Wakisaka M; Sato Y; Yoshinari M; Nunoi K; Ochi N; Fujishima M
Diabetes Res Clin Pract; 1994 Jan; 22(2-3):129-37. PubMed ID: 8200294
[TBL] [Abstract][Full Text] [Related]
18. Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice.
Meier M; Menne J; Haller H
Diabetologia; 2009 May; 52(5):765-75. PubMed ID: 19238353
[TBL] [Abstract][Full Text] [Related]
19. Tight blood glycaemic and blood pressure control in experimental diabetic nephropathy reduces extracellular matrix production without regression of fibrosis.
Conway BR; Betz B; Sheldrake TA; Manning JR; Dunbar DR; Dobyns A; Hughes J; Mullins JJ
Nephrology (Carlton); 2014 Dec; 19(12):802-13. PubMed ID: 25196678
[TBL] [Abstract][Full Text] [Related]
20. Chronic bilateral renal denervation attenuates renal injury in a transgenic rat model of diabetic nephropathy.
Yao Y; Fomison-Nurse IC; Harrison JC; Walker RJ; Davis G; Sammut IA
Am J Physiol Renal Physiol; 2014 Aug; 307(3):F251-62. PubMed ID: 24899056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
